CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4 Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Systems of Care for ST-Segment–Elevation Myocardial Infarction: A Policy Statement From the American Heart Association Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy ST-Segment Elevation Myocardial Infarction Patients in the Coronary Care Unit Is it Time to Break Old Habits? Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials

Original ResearchVolume 74, Issue 4, July 2019

JOURNAL:J Am Coll Cardiol. Article Link

Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction

R Twerenbold, JP Costabel, T Nestelberger et al. Keywords: 0/1-h algorithm; acute myocardial infarction; high-sensitivity cardiac troponin; outcome; rule-out; safety

ABSTRACT


BACKGROUND - The European Society of Cardiology (ESC) recommends the 0/1-h algorithm for rapid triage of patients with suspected nonST-segment elevation myocardial infarction (MI). However, its impact on patient management and safety when routinely applied is unknown.

 

OBJECTIVES - This study sought to determine these important real-world outcome data.

 

METHODS - In a prospective international study enrolling patients presenting with acute chest discomfort to the emergency department (ED), the authors assessed the real-world performance of the ESC 0/1-h algorithm using high-sensitivity cardiac troponin T embedded in routine clinical care and its associated 30-day rates of major adverse cardiac events (MACE) (the composite of cardiovascular death and MI).

 

RESULTS - Among 2,296 patients, nonST-segment elevation MI prevalence was 9.8%. In median, 1-h blood samples were collected 65 min after the 0-h blood draw. Overall, 94% of patients were managed without protocol violations, and 98% of patients triaged toward rule-out did not require additional cardiac investigations including high-sensitivity cardiac troponin T measurements at later time points or coronary computed tomography angiography in the ED. Median ED stay was 2 h and 30 min. The ESC 0/1-h algorithm triaged 62% of patients toward rule-out, and 71% of all patients underwent outpatient management. Proportion of patients with 30-day MACE were 0.2% (95% confidence interval: 03% to 0.5%) in the rule-out group and 0.1% (95% confidence interval: 0% to 0.2%) in outpatients. Very low MACE rates were confirmed in multiple subgroups, including early presenters.

 

CONCLUSIONS - These real-world data document the excellent applicability, short time to ED discharge, and low rate of 30-day MACE associated with the routine clinical use of the ESC 0/1-h algorithm for the management of patients presenting with acute chest discomfort to the ED.